Back to search
FDAFDA · Food and drugs·Recall number Z-1114-2023

Surgical convenience kits labeled as: MEDLINE BREAST BIOPSY KIT, Reorder Number DYNDA1224B

Published February 22, 2023 · Recall initiated: December 7, 2022

Summary

FDA records medical device Class II recall Z-1114-2023, published February 22, 2023 and initiated December 7, 2022. Recalling firm: MEDLINE INDUSTRIES, LP - Northfield; Status: Ongoing; Reported quantity: 60 units; Lot: GTIN 40193489468510, Lot # 22HMD545. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The recall is due to the perforated bag not allowing for outside of the kit wrapping to be sterile, therefore, only the contents inside the kits wrapping are sterile.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MEDLINE INDUSTRIES, LP - Northfield
Distributor
Nationwide
Lot
GTIN 40193489468510, Lot # 22HMD545
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Surgical convenience kits labeled as: MEDLINE BREAST BIOPSY KIT, Reorder Number DYNDA1224B recalled?

Yes. FDA published recall Z-1114-2023 on February 22, 2023. Reported hazard: The recall is due to the perforated bag not allowing for outside of the kit wrapping to be sterile, therefore, only the contents inside the kits wrapping are sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Letter